Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Thallion Pharmaceuticals Inc V.TLN

Healthcare Biotechnology


TSXV:TLN - Post by User

Thallion Pharmaceuticals Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by Everswanon Jun 22, 2009 1:51pm
97 Views
Post# 16089092

KRAS mut validated by ASCO

KRAS mut validated by ASCO
https://www.ajho.com/ASCO-provisional-clinical-opinion-on-KRAS-testing/article/138325/

Awaiting FDA blessing.
Another scientific confirmation of 4601 value.

New Thallion has cash to weather it out, regardless of market conditions, which are predicted to deteriorate.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities